Why Large Capital Projects Need a Different Operating Model In large pharmaceutical capital projects, speed is always a priority. But one part of the process still tends to slow everything down: commissioning, qualification and validation. The issue is not expertise. It is the way CQV is still often organised. On complex projects, paper-based workflows, sequential…
When Validation Becomes the Bottleneck Read More »
The kitchen Story “A pharmaceutical plant is just like a big kitchen. Our role is to help the client decide what they want to cook, choose the right equipment, install it properly, and show them how to use it. Because buying the right oven doesn’t guarantee a good pizza — you also need the right
Designing a pharmaceutical facility is like designing a kitchen… Here’s Why Read More »
Conversation That Matters No deviation’s Takeaways from KNEAT VALIDATE 2025: accelerating digital maturity Topic: Identifying and Controlling CQV Costs in the Digital Era Speaker: Patrick Mullin – Commissioning and Qualification Lead -Sanofi “The low-hanging fruit is gone.”That’s how Patrick Mulin, opened his session at VALIDATE. And from the moment he said it, the tone was
CQV, Cost Control and Digital Maturity: Insights from Sanofi at VALIDATE Read More »
Through the many different iterations of the CQV model, from the traditional V-model to the hybrid approach to the risk-based approach, a significant amount of time and effort has been spent demonstrating to regulatory inspectors…
A practical guide to lean CQV (Commissioning, Qualification, Validation) Read More »
2 Venture Drive, #08-10/11,
Vision Exchange
Singapore 608526